Byron Nash Renal Medullary Carcinoma Awareness Act of 2021
Summary
Byron Nash Renal Medullary Carcinoma Awareness Act of 2021 This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2021
Committee Review
Floor Vote
President
Introduced Jan 4, 2021
Last action Feb 2, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Feb 2, 2021
Committee
Referred to the Subcommittee on Health.
lower
Jan 4, 2021
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jan 4, 2021
Introduced
Introduced in House
lower
1 primary · 8 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 124
Scope: US
Hi! I can help you understand HR 124. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline